You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

1-alpha-hydroxylase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Secondary Hyperparathyroidism Trial in Baltimore (Teriparatide)

Completed
Has Results
  • Secondary Hyperparathyroidism
  • Baltimore, Maryland
    University of Maryland School of Medicine Division of Endocrinol
Mar 30, 2022

Baby Detect : Genomic Newborn Screening

Recruiting
  • Congenital Adrenal Hyperplasia
  • +126 more
    • Liege, Wallonia, Belgium
      CRMN, Hôpital La Citadelle
    Jan 24, 2023

    24-hydroxylase Deficiency Trial in Rochester

    Recruiting
    • 24-hydroxylase Deficiency
      • Rochester, Minnesota
        Mayo Clinic
      Feb 28, 2022

      Carcinoid Syndrome, Metastatic Nonfunctional Well Differentiated Neuroendocrine Tumor Trial in Detroit (other, procedure, drug)

      Recruiting
      • Carcinoid Syndrome
      • Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
      • Carbon C 11 Alpha-methyltryptophan
      • +3 more
      • Detroit, Michigan
        Wayne State University/Karmanos Cancer Institute
      Mar 30, 2022

      Alpha-1 Antitrypsin Deficiency Trial in Gainesville (Alpha-1 Antitrypsin Genotype)

      Recruiting
      • Alpha-1 Antitrypsin Deficiency
      • Alpha-1 Antitrypsin Genotype
      • Gainesville, Florida
        University of Florida
      Nov 2, 2022

      Alpha 1-Antitrypsin Deficiency Trial in Charleston (KB408 (Nebulization))

      Not yet recruiting
      • Alpha 1-Antitrypsin Deficiency
      • KB408 (Nebulization)
      • Charleston, South Carolina
        Medical University of South Carolina
      Sep 20, 2023

      Alpha-1 Antitrypsin Deficiency Trial in San Diego, Boston, Saint Louis (Liver Biopsy (Biopsy Group Only))

      Recruiting
      • Alpha-1 Antitrypsin Deficiency
      • Liver Biopsy (Biopsy Group Only)
      • San Diego, California
      • +2 more
      Dec 13, 2022

      DiabetesType 1 Trial (Placebo, Alpha Lipoic Acid 600 MG Oral Capsule)

      Not yet recruiting
      • Diabetes MellitusType 1
      • Placebo
      • Alpha Lipoic Acid 600 MG Oral Capsule
      • (no location specified)
      Jan 8, 2023

      Alpha1-Antitrypsin Deficiency Trial in United States (Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human))

      Recruiting
      • Alpha1-Antitrypsin Deficiency
      • Alpha-1 15%
      • Liquid Alpha1-Proteinase Inhibitor (Human)
      • Gainesville, Florida
      • +5 more
      Jan 13, 2023

      Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection)

      Not yet recruiting
      • Alpha1-Antitrypsin Deficiency
      • Fazirsiran Injection
      • (no location specified)
      Jun 16, 2023

      Phenylketonuria Trial in Ankara (SAR444836)

      Recruiting
      • Phenylketonuria
      • Ankara, Turkey
        Investigational Site Number: 7920001
      Aug 7, 2023

      Alpha-1 Foundation DNA and Tissue Bank

      Enrolling by invitation
      • Alpha 1 Antitrypsin Deficiency
        • Gainesville, Florida
          University of Florida
        Sep 19, 2022

        Cardiac Functions in Type 1 Diabetes Mellitus

        Not yet recruiting
        • Diabetes Mellitus, Type 1
        • +2 more
        • transthoracic echocardiography
        • (no location specified)
        Nov 12, 2023

        Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )

        Recruiting
        • Type1diabetes
        • +2 more
        • Infusion of GIP[1-42], GIP[1-30] or placebo
        • Hellerup, Copenhagen, Denmark
          Center for Clinical Metabolic Research, Gentofte Hospital
        Nov 17, 2023

        Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate, Placebo, Hydrocortisone)

        Withdrawn
        • Congenital Adrenal Hyperplasia
        • Abiraterone acetate
        • +3 more
        • Los Angeles, California
        • +3 more
        Jan 30, 2023

        Bronchiectasis Adult Trial in Dundee (Alpha 1-Proteinase Inhibitor 180mg/kg, Alpha 1-Proteinase Inhibitor 120mg/kg, Sodium

        Not yet recruiting
        • Bronchiectasis Adult
        • Alpha 1-Proteinase Inhibitor 180mg/kg
        • +2 more
        • Dundee, United Kingdom
          NHS Tayside
        Oct 12, 2022

        NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

        Recruiting
        • Non-small Cell Lung Cancer
        • Hypofractionated radiotherapy
        • +4 more
        • Guangzhou, Guangdong, China
          Sun yat-sen university cancer center
        Nov 14, 2023

        COPD Exacerbation Blood and Urine Biomarkers Study

        Recruiting
        • Chronic Obstructive Pulmonary Disease
        • +2 more
          • New York, New York
            Columbia University Medical Center
          Oct 11, 2022

          HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

          Recruiting
          • HLA-A2 Positive Cells Present
          • Refractory Melanoma
          • Alpha-type-1 Polarized Dendritic Cells
          • +5 more
          • Buffalo, New York
            Roswell Park Cancer Institute
          Dec 12, 2022

          Intrauterine Growth Restriction in Pre-eclamptic Women

          Not yet recruiting
          • alpha1 Anti-trypsin
          • +2 more
          • Alpha1 -Antitrypsin level
          • (no location specified)
          Nov 18, 2022

          COPD (COPD), Alpha1-Antitrypsin Deficiency Trial (ARALAST NP, Another Available A1PI)

          Not yet recruiting
          • Chronic Obstructive Pulmonary Disease (COPD)
          • Alpha1-Antitrypsin Deficiency
          • ARALAST NP
          • Another Available A1PI
          • (no location specified)
          Jul 18, 2022

          Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Charleston (ADVM-043)

          Completed
          Has Results
          • Alpha 1-Antitrypsin Deficiency
          • ADVM-043
          • Gainesville, Florida
          • +1 more
          Aug 3, 2022

          Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection, Placebo)

          Not yet recruiting
          • Alpha1-Antitrypsin Deficiency
          • Fazirsiran Injection
          • Placebo
          • (no location specified)
          Feb 2, 2023

          Coronary Artery Disease Trial in United Kingdom (BioMatrix Alpha)

          Not yet recruiting
          • Coronary Artery Disease
          • BioMatrix Alpha
          • Birmingham, United Kingdom
          • +5 more
          Mar 23, 2023

          Alpha1-Antitrypsin Deficiency Trial in Aomori, Hokkaido, Tokyo (Alpha-1 MP)

          Completed
          Has Results
          • Alpha1-Antitrypsin Deficiency
          • Alpha-1 MP
          • Aomori, Japan
          • +2 more
          Mar 22, 2022